Worldwide Parenteral Nutrition Market is Expected to Grow at a CAGR of over 6.0% During 2022-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Parenteral Nutrition Market Size, Share & Trends Analysis Report by Nutrient Type (Trace Elements, Single-dose Amino Acid Solution, Parenteral Lipid Emulsion), by Region (North America, APAC), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.

The global parenteral nutrition market size is expected to reach USD 10.7 billion by 2030 and is expected to expand at a CAGR of 6.0% over the forecast period. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients, and growing awareness pertaining to hospital-related malnutrition are a few key factors increasing the adoption of parenteral nutrition.

Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and growing preference for enteral nutrition among patients are major factors restricting the market growth.

With the increasing population, healthcare costs and food expenditure for a household and the nation are growing. Hence, a higher birth rate is expected to impact nutrition level, thereby acting as a driver for the market. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth.

Realized natality has been growing in the last decade and is anticipated to maintain growth over the forecast period. In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) is 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide.

Parenteral Nutrition Market Report Highlights

• Key players operating in the market are mainly focused on enhancing patient safety. Companies are also focusing on advancing their PN products to complement the parenteral nutrition compounding by incorporating technologies, such as barcode-assisted medication
• The ability to provide improved lipid and protein formulations to patients is one of the key parameters that companies leverage to differentiate their products from competitors.
• Also, high infection rate, poor water quality and sanitation facilities, and lack of awareness are prevalent factors increasing the incidence of malnourishment in developing nations, which creates a significant demand for PN sources, thereby aiding market growth
• The single-dose amino acid solution nutrient type segment dominated the market in 2021 due to the introduction of newly available amino acid solutions with minimal side effects
• North America dominated the global market in 2021 owing to the rising incidence of chronic conditions & malnutrition, coupled with increasing U.S. FDA approvals in the region

Companies Mentioned

• B. Braun Melsungen AG
• Fresenius Kabi AG
• Allergan
• Grifols, S.A.
• Pfizer, Inc.(Hospira)
• Otsuka Pharmaceutical Factory, Inc.
• Baxter
• Aculife (Nirlife)
• Sichuan Kelun Pharmaceutical Co. Ltd
• Vifor Pharma

Key Topics Covered:

Chapter 1 Methodology and Scope

1.1 Research Process

1.2 Information Procurement

1.3 Research Methodology

1.4 Research Scope and Assumptions

1.5 Research Methodology

1.6 List To Data Nutrient Type

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

2.4 Parenteral Nutrition Market Snapshot

Chapter 3 Parenteral Nutrition Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.1.1 Parent Market Outlook

3.1.2 Ancillary Market Outlook

3.2 Penetration And Growth Prospect Mapping

3.3 User Perspective Analysis

3.3.1 Consumer Behavior Analysis

3.3.2 Market Influencer Analysis

3.4 Regulatory Framework

3.4.1 Reimbursement Framework

3.4.2 Standards & Compliances

3.5 Market Variable Analysis

3.5.1 Market Driver Analysis

3.5.2 Market Restraint Analysis

3.5.2 Industry Challenges

3.6 Parenteral Nutrition Market: Analysis Tools

3.6.1 Porter’s Five Forces Analysis

3.6.2 Pestel Analysis

3.6.3 Major Deals & Strategic Alliances Analysis

3.6.4 Market Entry Strategies

3.7 Impact of COVID-19 on Parenteral Nutrition Market.

Chapter 4 Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

4.1 Segment Dashboard

4.2 Parenteral Nutrition Market: Nutrient Type Movement Analysis, USD Million, 2021 & 2030

4.2.1 Carbohydrates

4.2.2 Parenteral Lipid Emulsion

4.2.3 Single Dose Amino Acid Solution

4.2.4 Trace Elements

4.2.5 Vitamins & Minerals

Chapter 5 Parenteral Nutrition Market: Competitive Analysis

5.1 Company Market Position Analysis

5.2 Strategic Framework

Chapter 6 Parenteral Nutrition Market: Regional Estimates & Trend Analysis: By Nutrient Type

6.1 Regional Market Snapshot

6.2 Parenteral Nutrition Market: Regional Movement Analysis, USD Million, 2021 & 2030 (USD Million)

6.3 North America

6.3.1 North America Parenteral Nutrition Market Estimates And Forecasts, 2016 – 2030 (USD Million)

6.3.2 U.S.

6.3.3 Canada

6.4 Europe

6.4.1 Europe Parenteral Nutrition Market Estimates And Forecasts, 2016 – 2030 (USD Million)

6.4.2 Germany

6.4.3 U.K.

6.4.4 Italy

6.4.5 Spain

6.4.6 France

6.5 Asia Pacific

6.5.1 Asia Pacific Parenteral Nutrition Market Estimates And Forecasts, 2016 – 2030 (USD Million)

6.5.2 China

6.5.3 India

6.5.4 Japan

6.5.5 Thailand

6.6.6 South Korea

6.7 Latin America

6.7.1 Latin America parenteral nutrition market estimates and forecasts, 2016 – 2030 (USD Million)

6.7.2 Brazil

6.7.3 Mexico

6.7.4 Argentina

6.7.5 Colombia

6.8 MEA

6.8.1 MEA parenteral nutrition market estimates and forecastss, 2016 – 2030 (USD Million)

6.8.2 SOUTH AFRICA

6.8.3 Saudi Arabia

6.8.4 UAE

Chapter 7 Competitive Landscape

7.1 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/ua51ff

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900